Literature DB >> 24179910

The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study.

Shobha Sharma1, Kailash Chandra Aggarwal, Shivani Deswal, Deepak Raut, Neelam Roy, Rohit Kapoor.   

Abstract

BACKGROUND: Malaria is a major public health problem in the south-east Asian region. Among all countries in the SE Asian region the highest number of cases and deaths are reported from India. Children below 14 years of age contribute to approximately 42% of all the deaths. A majority of the deaths are attributed to severe malaria which is caused by Plasmodium falciparum. It is considered that causes a benign causing febrile illness without significant complications. However, in recent years, the spectrum of is shifting from being the cause of benign fever, to more severe complications. There have been case reports of complications like thrombocytopaenia, cerebral malaria, a disseminated intravascular coagulation, the acute respiratory distress syndrome, hepatic dysfunction and renal involvement. Most of the case reports are from the adult population, with an occasional occurrence of paediatric cases.
OBJECTIVE: To highlight the increasing number of severe manifestations in P.vivax malaria in the children who were admitted in the malaria transmission season of 2011, at a tertiary care hospital.
DESIGN: A descriptive, cross-sectional study. STUDY
SUBJECTS: Children with an acute febrile illness of a duration of < 7 days, which was confirmed as Plasmodium vivax positive malaria by testing the peripheral smears and/or by Rapid Diagnostic Testing, who were admitted in the paediatric ward of a tertiary care hospital in New Delhi (India), during May 2011 to October 2011, Case records of context cases were analysed retrospectively. STATISTICS: The data was summarised by calculating the rates, ratios, proportions, means, standard deviations and the 95% confidence intervals. The Chi square test was applied to assess the significant difference between two qualitative variables.
RESULTS: Among the case records of 54 patients, 40.7% were below 5 years. 61% were males and 38.9% were females. Besides hepatomegaly and splenomegaly which were the most common symptoms, which were seen in 81.5% and 72.2% children respectively, the various unusual manifestations seen were severe thrombocytopaenia (37%), jaundice with deranged LFT values (25.9%), abnormal bleeding (18.5%), impaired consciousness with a GCS of < 9 (18.5%), severe anaemia (14.8%), hypotension (11.1%), repeated convulsions (7.6%), pulmonary oedema/ARDS (5.6%) and ascites (5.6%). One case each showed haemoglobinuria, and pleural effusion.
CONCLUSION: Plasmodium vivax is emerging as a cause of severe malaria. There is a further need to study the pathophysiology, virulence factors and the molecular mechanisms which are involved in malaria.

Entities:  

Keywords:  Children; Complications; Plasmodium vivax malaria

Year:  2013        PMID: 24179910      PMCID: PMC3809649          DOI: 10.7860/JCDR/2013/5633.3370

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  29 in total

1.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

2.  Factors contributing to anemia after uncomplicated falciparum malaria.

Authors:  R N Price; J A Simpson; F Nosten; C Luxemburger; L Hkirjaroen; F ter Kuile; T Chongsuphajaisiddhi; N J White
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  Unusual presentation of Plasmodium vivax malaria with severe thrombocytopenia and acute renal failure.

Authors:  Dilpreet Kaur; Vani Wasir; Sheffali Gulati; Arvind Bagga
Journal:  J Trop Pediatr       Date:  2007-01-30       Impact factor: 1.165

5.  Thrombocytopenia in malaria.

Authors:  S Looareesuwan; J G Davis; D L Allen; S H Lee; D Bunnag; N J White
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-03       Impact factor: 0.267

6.  Plasmodium vivax malaria in children: uncommon manifestations.

Authors:  A Parakh; N Agarwal; A Aggarwal; A Aneja
Journal:  Ann Trop Paediatr       Date:  2009-12

Review 7.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Acute lung injury and other serious complications of Plasmodium vivax malaria.

Authors:  Lionel K K Tan; Sophie Yacoub; Sarah Scott; Sanjay Bhagani; Michael Jacobs
Journal:  Lancet Infect Dis       Date:  2008-07       Impact factor: 25.071

9.  High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions.

Authors:  Sarwo Handayani; Daniel T Chiu; Emiliana Tjitra; Jason S Kuo; Daniel Lampah; Enny Kenangalem; Laurent Renia; Georges Snounou; Ric N Price; Nicholas M Anstey; Bruce Russell
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

10.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more
  9 in total

1.  Malaria Severity in Mangaluru City in the Southwestern Coastal Region of India.

Authors:  Kiran K Dayanand; Punnath Kishore; Valleesha Chandrashekar; Rajeshwara N Achur; Susanta K Ghosh; Srinivas B Kakkilaya; Suchetha N Kumari; Satyanarayan Tiwari; Archith Boloor; Rajeshwari Devi; D Channe Gowda
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

2.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

3.  Bilateral Cervical Lymphadenopathy Atypical Presentation of Malaria-A Rare Case Report.

Authors:  Dwijen Das; Kallol Bhattacharjee; Surinder Ghintala; Amit Kr Kalwar
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 4.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  Development of Visually Improved Loop Mediated Isothermal Amplification for the Diagnosis of Plasmodium vivax Malaria in a Tertiary Hospital in Chandigarh, North India.

Authors:  Hargobinder Kaur; Rakesh Sehgal; Devendra Bansal; Ali A Sultan; Ashish Bhalla; Sunit C Singhi
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

Review 6.  Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis.

Authors:  Cho Naing; Maxine A Whittaker; Victor Nyunt Wai; Joon Wah Mak
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

7.  Imported Plasmodium vivax malaria with severe thrombocytopaenia: can it be severe malaria or not?

Authors:  Spinello Antinori; Alberto Corona; Anna Lisa Ridolfo; Laura Galimberti; Davide Ricaboni; Laura Milazzo; Mario Corbellino
Journal:  Malar J       Date:  2016-02-19       Impact factor: 2.979

8.  Vivax malaria in an Amazonian child with dilated cardiomyopathy.

Authors:  Antonio C Martins; Jamille B Lins; Luana M N Santos; Licia N Fernandes; Rosely S Malafronte; Teresa C Maia; Melissa C V Ribera; Ricardo B Ribera; Monica da Silva-Nunes
Journal:  Malar J       Date:  2014-02-18       Impact factor: 2.979

9.  Exploration of genetic diversity of Plasmodium vivax circumsporozoite protein (Pvcsp) and Plasmodium vivax sexual stage antigen (Pvs25) among North Indian isolates.

Authors:  Hargobinder Kaur; Rakesh Sehgal; Archit Kumar; Alka Sehgal; Praveen K Bharti; Devendra Bansal; Pradyumna K Mohapatra; Jagadish Mahanta; Ali A Sultan
Journal:  Malar J       Date:  2019-09-06       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.